(R)-3-Nitrobiphenyline
|  | |
| Systematic (IUPAC) name | |
|---|---|
| (R)-2-[1-(3'-Nitrobiphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole | |
| Clinical data | |
| MedlinePlus | a682611 | 
| Identifiers | |
| PubChem | CID 16757089 | 
| ChemSpider | 23288036  | 
| ChEMBL | CHEMBL242693  | 
| Chemical data | |
| Formula | C17H17N3O3 | 
| Molar mass | 311.334 g/mol | 
| 
 | |
| 
 | |
| (verify) | |
(R)-3-Nitrobiphenyline is a drug which acts as an α2-adrenergic agonist, selective for the α2C subtype, as well as being a weak antagonist at the α2A and α2B subtypes.[1]
References
- ↑ Crassous PA, Cardinaletti C, Carrieri A, Bruni B, Di Vaira M, Gentili F, Ghelfi F, Giannella M, Paris H, Piergentili A, Quaglia W, Schaak S, Vesprini C, Pigini M (August 2007). "Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist". Journal of Medicinal Chemistry 50 (16): 3964–8. doi:10.1021/jm061487a. PMID 17630725.
This article is issued from Wikipedia - version of the Monday, December 16, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.